Quantcast
Utah

Top court hearing Utah firm's case as groups fight Myriad Genetics' gene patenting

Comments

Return To Article
  • CPelkey Laramie, WY
    April 15, 2013 6:07 a.m.

    I don't mean to be picky, but this story - and a host of others around the country this day - make the same oversight. The sentence that starts with "Women with BRCA mutations...."

    As a male breast cancer patient, I am particularly bothered by that omission. Obviously, breast cancer is a major concern among women, but men, too, can suffer from the BRCA1 and BRCA2 mutations and it increases the risk of male breast cancer from 0.05% to 7%. Breast Cancer in men can be even more dangerous, largely because symptoms are often ignored., too, can suffer from the BRCA1 and BRCA2 mutations and it increases the risk of male breast cancer from 0.05% to 7%. Breast Cancer in men can be even more dangerous, largely because symptoms are often ignored.

    It's a small omission, but it could contribute to a fatal mistake.

  • casual observer Salt Lake City, UT
    April 15, 2013 11:43 a.m.

    The ACLU and others want all the benefits of very expensive genetic research, but they don't want to encourage it by offering patent protection to those who invest $100s of millions in it. Hopefully the SCOTUS knows that you can't have it both ways.